Monthly Spotlight: Elizabeth McDermott, Founder, Ferolyn Fellowship

Unconditional passion for the industry. A patient-first mindset. Grit. A selfless willingness to give back to the field to help advance the next generation of entrepreneurs and inventors.

These are just a few of the traits that describe the individuals drawn to the medical device industry, and one of the aspects that makes it so unique and strong.

Dr. Fogarty Continues His Legacy at Age 84, With No Signs of Slowing Down

With age, comes wisdom, and although no one who knows Dr. Fogarty would call him “old,” there’s no doubt his wisdom benefits us all.

Dr. Fogarty, who celebrated his 84th birthday on February 25, is an inspiration to us all. Most of us know his many accomplishments, but for those who don’t, he is one of the most notable cardiovascular surgeons and innovators of all time and recipient of the prestigious Presidential National Medal of Technology and Innovation,

Mike Regan Joins the Fogarty Institute as Chief Innovation Officer

As the Fogarty Institute continues to expand and strengthen its services and broaden its relationships, it has hired medtech industry professional Michael (Mike) Regan as chief innovation officer.

Mike comes to the Institute with 35 years of industry experience, spanning a broad range of positions in general management, product development, operations, sales and marketing,

A 38-year-old patient immediately after being treated with CyberHeart’s technology

CyberHeart, a startup that is developing the world’s first non-invasive treatment for cardiac arrhythmias, has experienced tremendous clinical successes in the past few months.

“This is a game changer,” (for patients with irregular heart rhythm), said Dr. Melvin Scheinman, a professor of medicine at the University of California, San Francisco, and past president of the Heart Rhythm Society,

Clinical Evidence and Health Economics

Seminar Reviews the Importance of Clinical Evidence and Health Economics in Getting to Market

Many medical device entrepreneurs believe that the single most important milestone to achieve in gaining market adoption of their technology is regulatory approval. While certainly an essential step, it is often not sufficient.